Showing results (11-20 of 310) with videos related to
Sort By:
Pageof 31
Gastroenterology Clinics of North America|May 19, 2009
Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the futureStefano FiorucciThe Journal of Pharmacology and Experimental Therapeutics|April 30, 2005
A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosisStefano Fiorucci, Giovanni Rizzo, Elisabetta Antonelli, et al.Journal of Hepatology|December 4, 2003
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liverStefano Fiorucci, Elisabetta Antonelli, Vincenzo Brancaleone, et al.The Journal of Pharmacology and Experimental Therapeutics|September 30, 2005
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channelsEleonora Distrutti, Luca Sediari, Andrea Mencarelli, et al.Proceedings of the National Academy of Sciences of the United States of America|November 13, 2002
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in miceStefano Fiorucci, Elisabetta Antonelli, Eleonora Distrutti, et al.British Journal of Pharmacology|February 9, 2002
A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathwayStefano Fiorucci, Elisabetta Antonelli, Andrea Mencarelli, et al.Liver Research|February 17, 2025
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver diseaseMichele Biagioli, Stefano FiorucciCurrent Opinion in Pharmacology|June 17, 2006
PPARs and other nuclear receptors in inflammationGiovanni Rizzo, Stefano FiorucciJournal of Cellular and Molecular Medicine|January 1, 2010
FXR an emerging therapeutic target for the treatment of atherosclerosisAndrea Mencarelli, Stefano FiorucciPharmacological Research|August 1, 2016
Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertensionStefano Fiorucci, Eleonora DistruttiPageof 31